Items where authors include "Brooks, R"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Collado-González, M, Kaur, G, González-Espinosa, Y et al. (2 more authors) (2020) Characterisation of the Interaction among Oil-In-Water Nanocapsules and Mucin. Biomimetics, 5 (3). 36. ISSN 2313-7673

Kevill, A orcid.org/0000-0002-0536-5610, Brooks, R and Mallinson, K (2020) From pipe dream, to enterprise incubator, to award-winning business: The case of Scriba PR. The International Journal of Entrepreneurship and Innovation, 21 (2). pp. 127-135. ISSN 1465-7503

Conference or Workshop Item

Collado-González, M, Kaur, G, González-Espinosa, Y et al. (2 more authors) (2022) On the Importance of Mucin Corona to prevent Nanocapsules Aggregation for Oral Delivery. In: The 7th World Congress on Recent Advances in Nanotechnology, 02-16 Apr 2022, Online.